Contrast-Enhanced Mammography: Technique, Indications, and Review of Current Literature
Open Access
- 3 November 2021
- journal article
- review article
- Published by Springer Nature in Current Radiology Reports
- Vol. 9 (11) , 1-14
Abstract
Purpose of Review: To provide an update on contrast-enhanced mammography (CEM) regarding current technique and interpretation, the performance of this modality versus conventional breast imaging modalities (mammography, ultrasound, and MRI), existing clinical applications, potential challenges, and pitfalls. Recent Findings: Multiple studies have shown that the low-energy, non-contrast-enhanced images obtained when performing CEM are non-inferior to full-field digital mammography with the added benefit of recombined post-contrast images, which have been shown to provide comparable information compared to MRI without sacrificing sensitivity and negative predictive values. While CEMs' usefulness for further diagnostic characterization of indeterminate breast findings is apparent, additional studies have provided strong evidence of potential roles in screening intermediate to high-risk populations, evaluation of disease extent, and monitoring response to therapy, particularly in patients in whom MRI is either unavailable or contraindicated. Others have shown that some patients prefer CEM over MRI given the ease of performance and patient comfort. Additionally, some health systems may find significantly reduced costs compared to MRI. Currently, CEM is hindered by the limited availability of CEM-guided tissue sampling and issues of intravenous contrast administration. However, commercially available CEM-guided biopsy systems are on the horizon, and small changes in practice workflow can be quickly adopted. As of now, MRI remains a mainstay of high-risk screening, evaluation of the extent of disease, and monitoring response to therapy, but smaller studies have suggested that CEM may be equivalent to MRI for these indications, and larger confirmatory studies are needed. Summary: CEM is an emerging problem-solving breast imaging modality that provides complementary information to conventional imaging modalities and may potentially be used in place of MRI for specific indications and/or patient populations.Keywords
This publication has 76 references indexed in Scilit:
- Dual-energy contrast-enhanced digital mammography: initial clinical results of a multireader, multicase studyBreast Cancer Research, 2012
- Spectrum of Diseases Presenting as Architectural Distortion on Mammography: Multimodality Radiologic Imaging with Pathologic CorrelationSeminars in Ultrasound, CT and MRI, 2011
- Increasing Accuracy of Detection of Breast Cancer with 3-T MRIAmerican Journal of Roentgenology, 2009
- Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer ScreeningNew England Journal of Medicine, 2005
- Distorsions architecturales et difficultés diagnostiquesJournal de Radiologie, 2004
- Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic PredispositionNew England Journal of Medicine, 2004
- Mammographic Screening for Breast CancerNew England Journal of Medicine, 2003
- Likelihood of Malignant Disease for Various Categories of Mammographically Detected, Nonpalpable Breast LesionsMayo Clinic Proceedings, 1993
- Reproductive, Developmental, and Genetic Toxicology of IoversolInvestigative Radiology, 1989
- Toxicology of IohexolInvestigative Radiology, 1985